ArticleGut and liver2022

Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn's Disease Patients.

Eun Sil Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.